Core Viewpoint - Yinosh experienced a decline of 3.52% on October 13, with a trading volume of 58.50 million yuan, indicating a challenging market environment for the company [1] Financing Summary - On October 13, Yinosh had a financing buy-in amount of 6.76 million yuan and a financing repayment of 5.42 million yuan, resulting in a net financing buy of 1.34 million yuan [1] - As of October 13, the total financing and securities lending balance for Yinosh was 70.05 million yuan, which accounts for 1.78% of its market capitalization, indicating a low financing balance compared to the past year [1] - The company had no securities lending activity on October 13, with a securities lending balance of 0.00 shares, placing it at a high level compared to the past year [1] Company Overview - Shanghai Yinosh Biotechnology Co., Ltd. was established on May 12, 2010, and is located in the China (Shanghai) Pilot Free Trade Zone [1] - The company specializes in providing comprehensive research and development services (CRO) primarily focused on non-clinical research services, with 96.31% of its revenue coming from non-clinical services [1] Financial Performance - For the period from January to June 2025, Yinosh reported an operating income of 375 million yuan, a year-on-year decrease of 38.04%, and a net profit attributable to shareholders of -15.19 million yuan, reflecting a significant decline of 115.88% year-on-year [2] Shareholder Information - As of June 30, 2025, Yinosh had 5,386 shareholders, a decrease of 0.90% from the previous period, with an average of 5,235 circulating shares per person, which is an increase of 0.91% [2] - The company has distributed a total of 45.11 million yuan in dividends since its A-share listing [3] - Notable changes in institutional holdings include ICBC Medical Health Stock becoming the seventh largest shareholder, increasing its holdings by 72,300 shares, while new shareholders include ICBC Strategic Transformation Stock and Harvest Medical Health Stock [3]
益诺思10月13日获融资买入675.67万元，融资余额7005.10万元